Login Register Cart 0
Generic placeholder image

Current Pharmaceutical Design

Editor-in-Chief

ISSN (Print): 1381-6128
ISSN (Online): 1873-4286

Back
Journal Home About Journal Editorial Board Journal Insight Current Issue Volumes/Issues
Subscribe
Commentary

Opium, Street Opium, and Cancer Risk

Author(s): Miguel López-Lázaro*

Volume 28, Issue 25, 2022

Published on: 21 July, 2022

Page: [2039 - 2042] Pages: 4

DOI: 10.2174/1381612828666220607104805

Abstract

Opium is defined as the air-dried latex obtained by incision from the unripe capsules of Papaver somniferum L. Opium is a complex mixture that contains approximately 10% morphine and 2% codeine. It is commonly used to prepare opium tinctures for people with chronic diarrhea. Morphine and related opioids are powerful but highly addictive analgesics; designing less addictive opioids is an active area of pharmaceutical research that may lead to significant improvements in chronic pain management. Recently, the International Agency for Research on Cancer (IARC) has classified opium consumption as carcinogenic to humans (Group 1) based on sufficient evidence of carcinogenicity in human studies. However, all human studies analyzed by the IARC Working Group included participants who consumed opium that was mixed, adulterated, and/or contaminated with known and probable human carcinogens (e.g., tarry residues of combusted opium, arsenic, lead, and chromium). The working group considered that these carcinogens were part of the complex mixture that opium is, rather than co-exposure or confounders. No evidence of carcinogenicity was available for pure opium in human, animal, or mechanistic studies. To avoid confusion and concern among health professionals and patients using medicinal opium preparations and in scientists involved in the design and development of new opium derivatives, opium should be classified in Group 3 (not classifiable as to its carcinogenicity to humans). The term ‘street opium’ could be used to refer to opium that probably contains human carcinogens not present in pure opium and should remain in Group 1 (carcinogenic to humans).

Keywords: Carcinogenesis, IARC (international agency for research on cancer), opioids, Papaver somniferum, carcinogens, opium consumption.

Next »
[1]
European Pharmacopoeia. 10th Edition | EDQM - European Directorate for the Quality of Medicines 2021. Available from: https://www.edqm.eu/en/european-pharmacopoeia-ph-eur-10th-edition (Accessed on Oct 19, 2021).
[2]
Trease and Evans’ Pharmacognosy - 16th Edition 2009. Available from: https://www.elsevier.com/books/trease-and-evans-pharmacognosy/9780702029332
[3]
Schiller LR. Antidiarrheal drug therapy. Curr Gastroenterol Rep 2017; 19(5): 18.
[http://dx.doi.org/10.1007/s11894-017-0557-x] [PMID: 28397130]
[4]
Schiller LR, Pardi DS, Sellin JH. Chronic diarrhea: Diagnosis and management. Clin Gastroenterol Hepatol 2017; 15(2): 182-193.e3.
[http://dx.doi.org/10.1016/j.cgh.2016.07.028] [PMID: 27496381]
[5]
Brumand A, Carlson B, Sharma V. Tincture of opium in a refractory case of short bowel syndrome. Off. J Am Coll Gastroenterol ACG 2020; 115: S1445.
[http://dx.doi.org/10.14309/01.ajg.0000713648.34149.be]
[6]
Tabassomi F, Zarghami M, Shiran MR, Farnia S, Davoodi M. Opium tincture versus methadone syrup in management of acute raw opium withdrawal: A randomized, double-blind, controlled trial. J Addict Dis 2016; 35(1): 8-14.
[http://dx.doi.org/10.1080/10550887.2015.1074504] [PMID: 26566681]
[7]
Nikoo M, Moazen-Zadeh E, Nikoo N, et al. Comparing opium tincture and methadone for medication-assisted treatment of patients with opioid use disorder: Protocol for a multicenter parallel group noninferiority double-blind randomized controlled trial. Int J Methods Psychiatr Res 2019; 28(1): e1768.
[http://dx.doi.org/10.1002/mpr.1768] [PMID: 30714249]
[8]
Nikoo M, Nikoo N, Anbardan SJ, et al. Tincture of opium for treating opioid dependence: A systematic review of safety and efficacy. Addiction 2017; 112(3): 415-29.
[http://dx.doi.org/10.1111/add.13628] [PMID: 27740713]
[9]
Wood E, Simel DL, Klimas J. Pain management with opioids in 2019-2020. JAMA 2019; 322(19): 1912-3.
[http://dx.doi.org/10.1001/jama.2019.15802] [PMID: 31600370]
[10]
Kieffer BL. Drug discovery: Designing the ideal opioid. Nature 2016; 537(7619): 170-1.
[http://dx.doi.org/10.1038/nature19424] [PMID: 27533037]
[11]
Stein C. Opioid receptors. Annu Rev Med 2016; 67: 433-51.
[http://dx.doi.org/10.1146/annurev-med-062613-093100] [PMID: 26332001]
[12]
Varga BR, Streicher JM, Majumdar S. Strategies towards safer opioid analgesics-A review of old and upcoming targets.Br J Pharmacol. 2021; pp. 1-19.
[http://dx.doi.org/10.1111/bph.15760] [PMID: 34826881]
[13]
Kaski SW, White AN, Gross JD, Siderovski DP. Potential for Kappa-opioid receptor agonists to engineer nonaddictive analgesics: A narrative review. Anesth Analg 2021; 132(2): 406-19.
[http://dx.doi.org/10.1213/ANE.0000000000005309] [PMID: 33332902]
[14]
Volkow ND, Blanco C. The changing opioid crisis: Development, challenges and opportunities. Mol Psychiatry 2021; 26(1): 218-33.
[http://dx.doi.org/10.1038/s41380-020-0661-4] [PMID: 32020048]
[15]
Warnakulasuriya S, Cronin-Fenton D, Jinot J, et al. Carcinogenicity of opium consumption. Lancet Oncol 2020; 21(11): 1407-8.
[http://dx.doi.org/10.1016/S1470-2045(20)30611-2] [PMID: 33038940]
[16]
Opium Consumption | IARC Monographs on the Identification of Carcinogenic Hazards to Humans 2021. Available from: https://monographs.iarc.who.int/.
[17]
Asl SMS, Assareh M, Khodayar MJ, Mousavi Z. Investigating the source of contamination opioid into lead in forensic medicine. J Heavy Met Toxic Dis 2017; 2: 1-3.
[18]
Aghababaei R, Javadi I, Nili-Ahmadabadi A, Parsafar S, Ahmadimoghaddam D. Occurrence of bacterial and toxic metals contamination in illegal opioid-like drugs in Iran: A significant health challenge in drug abusers. Daru 2018; 26(1): 77-83.
[http://dx.doi.org/10.1007/s40199-018-0205-5] [PMID: 30159760]
[19]
Tabrizi R, Sarihi S, Moazzen F, et al. A systematic review and meta-analysis on blood lead level in opium addicts: An emerging health threat. Biol Trace Elem Res 2021; 199(10): 3634-41.
[http://dx.doi.org/10.1007/s12011-020-02504-1] [PMID: 33244670]
[20]
Hosseini M-S, Salimi A, Phillips S, Zamani N, Hassanian-Moghaddam H. Adult lead poisoning caused by contaminated opium: A two-year longitudinal follow-up study. Ann Glob Health 2021; 87(1): 89.
[http://dx.doi.org/10.5334/aogh.3420] [PMID: 34567981]
[21]
Narang APS, Chawla LS, Khurana SB. Levels of arsenic in Indian opium eaters. Drug Alcohol Depend 1987; 20(2): 149-53.
[http://dx.doi.org/10.1016/0376-8716(87)90064-0] [PMID: 2824159]
[22]
Ghane T, Zamani N, Hassanian-Moghaddam H, Beyrami A, Noroozi A. Lead poisoning outbreak among opium users in the Islamic Republic of Iran, 2016-2017. Bull World Health Organ 2018; 96(3): 165-72.
[http://dx.doi.org/10.2471/BLT.17.196287] [PMID: 29531415]
[23]
Agents Classified by the IARC Monographs, Volumes 1–129 – IARC Monographs on the Identification of Carcinogenic Hazards to Humans 2021. Available from: https://monographs.iarc.who.int/agents-classified-by-the-iarc/ (Accessed on Oct 19, 2021).
[24]
Malaveille C, Friesen M, Camus A-M, et al. Mutagens produced by the pyrolysis of opium and its alkaloids as possible risk factors in cancer of the bladder and oesophagus. Carcinogenesis 1982; 3(5): 577-85.
[http://dx.doi.org/10.1093/carcin/3.5.577] [PMID: 7046981]
[25]
Xue W, Warshawsky D. Metabolic activation of polycyclic and heterocyclic aromatic hydrocarbons and DNA damage: A review. Toxicol Appl Pharmacol 2005; 206(1): 73-93.
[http://dx.doi.org/10.1016/j.taap.2004.11.006] [PMID: 15963346]
[26]
Straif K, Loomis D, Guyton K, et al. Future priorities for the IARC monographs. Lancet Oncol 2014; 15: 683-4.
[http://dx.doi.org/10.1016/S1470-2045(14)70168-8]
[27]
Bartha S, Taut I, Goji G, Vlad IA, Dinulică F. Heavy metal content in polyfloralhoney and potential health risk. A case study of Copșa Mică, Romania. Int J Environ Res Public Health 2020; 17(5): 1507.
[http://dx.doi.org/10.3390/ijerph17051507] [PMID: 32111044]
[28]
Ru Q-M, Feng Q, He J-Z. Risk assessment of heavy metals in honey consumed in Zhejiang province, southeastern China. Food Chem Toxicol 2013; 53: 256-62.
[http://dx.doi.org/10.1016/j.fct.2012.12.015] [PMID: 23261649]
[29]
Liu Y, Wu F. Global burden of aflatoxin-induced hepatocellular carcinoma: A risk assessment. Environ Health Perspect 2010; 118(6): 818-24.
[http://dx.doi.org/10.1289/ehp.0901388] [PMID: 20172840]
[30]
Alzaidi MA, Arab HA, Amanpour S, Shirkoohi R, Muhammadnejad S, Sasani F. Opium consumption and the incidence of cancer: does opium account as an emerging risk factor for gastrointestinal cancer? J Gastrointest Cancer 2018; 49(2): 172-80.
[http://dx.doi.org/10.1007/s12029-017-0050-7] [PMID: 29362985]
[31]
Samet JM, Chiu WA, Cogliano V, et al. The IARC monographs: Updated procedures for modern and transparent evidence synthesis in cancer hazard identification. J Natl Cancer Inst 2020; 112(1): 30-7.
[http://dx.doi.org/10.1093/jnci/djz169] [PMID: 31498409]

Rights & Permissions Print Cite
Article Metrics
17
1
© 2024 Bentham Science Publishers | Privacy Policy